{"version":"1.0","provider_name":"PTS Granada - Parque Tecnol\u00f3gico de la Salud de Granada","provider_url":"https:\/\/pts.miguelangelpoyatos.com\/en\/","author_name":"Comunicaci\u00f3n PTS","author_url":"https:\/\/pts.miguelangelpoyatos.com\/en\/author\/oscar\/","title":"Mini linfocitos sint\u00e9ticos para el tratamiento del c\u00e1ncer","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"5Xkc5UE6Ha\"><a href=\"https:\/\/pts.miguelangelpoyatos.com\/en\/mini-linfocitos-sinteticos-para-el-tratamiento-del-cancer\/\">Mini linfocitos sint\u00e9ticos para el tratamiento del c\u00e1ncer<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pts.miguelangelpoyatos.com\/en\/mini-linfocitos-sinteticos-para-el-tratamiento-del-cancer\/embed\/#?secret=5Xkc5UE6Ha\" width=\"600\" height=\"338\" title=\"&#8220;Mini linfocitos sint\u00e9ticos para el tratamiento del c\u00e1ncer&#8221; &#8212; PTS Granada - Parque Tecnol\u00f3gico de la Salud de Granada\" data-secret=\"5Xkc5UE6Ha\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/pts.miguelangelpoyatos.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/orange-rhinoceros-572136.hostingersite.com\/wp-content\/uploads\/2024\/07\/GrupoAe23_ibsGRANADA-1.webp","thumbnail_width":1500,"thumbnail_height":1200,"description":"En #InnovacionPTS conocemos el trabajo de un equipo multidisciplinar del Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs.GRANADA), la Universidad de Granada (UGR) y del Centro de Investigaci\u00f3n Gen\u00f3mica y Oncol\u00f3gica (GENYO) en colaboraci\u00f3n con el Hospital Universitario Cl\u00ednico San Cecilio de Granada, que ha desarrollado un novedoso sistema para el tratamiento de c\u00e1ncer de mama triple negativo, uno de los m\u00e1s agresivos y de peor pron\u00f3stico en mujeres."}